Cargando…

Longitudinal assessment of adhesion to vascular cell adhesion molecule‐1 at steady state and during vaso‐occlusive crises in sickle cell disease

Sickle cell disease (SCD) is characterized by frequent and unpredictable vaso‐occlusive crises (VOCs). Sickle erythrocytes (SSRBCs) contribute to VOCs by participating in a series of adhesive events with blood cells and the vascular endothelium. Adhesion assays have been used to evaluate the relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Jennell, Callaghan, Michael U., Gao, Xiufeng, Liu, Ke, Zaidi, Ahmar, Tarasev, Michael, Hines, Patrick C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Haemoglobinopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299835/ https://www.ncbi.nlm.nih.gov/pubmed/34850378 http://dx.doi.org/10.1111/bjh.17954

Ejemplares similares

Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease
por: Hines, Patrick C., et al.
Publicado: (2021)

Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021)

Antithrombin‐III mitigates thrombin‐mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow
por: Wulftange, William J., et al.
Publicado: (2022)

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)

Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

S107: P-SELECTIN INHIBITOR INCLACUMAB REDUCES CELL ADHESION IN AN IN-VITRO ASSAYS SHOWING POTENTIAL FOR PREVENTION OF VASO-OCCLUSION EVENTS IN SICKLE CELL DISEASE
por: Tarasev, M, et al.
Publicado: (2022)

SLN124, a GalNac‐siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron‐overload in a mouse model of β‐thalassaemia
por: Vadolas, Jim, et al.
Publicado: (2021)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
por: Zaidi, Ahmar U., et al.
Publicado: (2021)

Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Alshahrani, Mohammed S., et al.
Publicado: (2021)

Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises
por: Boisson, Camille, et al.
Publicado: (2022)

Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients
por: Morikis, Vasilios A., et al.
Publicado: (2021)

Vaso-occlusive crises in patients with sickle cell disease: Parents' perspectives and association with disease outcomes
por: Zolaly, Mohammed, et al.
Publicado: (2019)

Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease
por: Gemel, Joanna, et al.
Publicado: (2022)

Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Akindele, Adebisi O, et al.
Publicado: (2022)

Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises
por: Soren, Uttam Kumar, et al.
Publicado: (2022)

The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises
por: Ballas, Samir K.
Publicado: (2017)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort Study
por: Darbari, Deepika S., et al.
Publicado: (2013)

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients
por: Bartolucci, Pablo, et al.
Publicado: (2016)

P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
por: Karki, Nabin Raj, et al.
Publicado: (2021)

The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
por: Delgado, Julio, et al.
Publicado: (2021)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

PB2511: CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN GERMANY
por: Udeze, Chuka, et al.
Publicado: (2023)

TGF-β1 Reduces Neutrophil Adhesion and Prevents Acute Vaso-Occlusive Processes in Sickle Cell Disease Mice
por: Torres, Lidiane S., et al.
Publicado: (2022)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
por: Shah, Nirmish, et al.
Publicado: (2019)

Oxygen gradient ektacytometry‐derived biomarkers are associated with vaso‐occlusive crises and correlate with treatment response in sickle cell disease
por: Rab, Minke A. E., et al.
Publicado: (2020)

P1447: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY
por: Udeze, Chuka, et al.
Publicado: (2023)

Emerging Therapies for the Management of Pain and Vaso-Occlusive Crises in Patients With Sickle Cell Disease: A Systematic Review of Randomized Controlled Trials
por: Lowe, Michael, et al.
Publicado: (2023)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
por: Demagny, Julien, et al.
Publicado: (2020)

Validation of patient‐reported vaso‐occlusive crisis day as an endpoint in sickle cell disease studies
por: Coyne, Karin S., et al.
Publicado: (2022)

Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease
por: Abdulwahab, Hawra, et al.
Publicado: (2021)

The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center study
por: Alkhalifah, Sahar Abdullah, et al.
Publicado: (2022)

Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?
por: Veluswamy, Saranya, et al.
Publicado: (2019)

Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
por: Rizio, Avery A., et al.
Publicado: (2020)

Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

Sickle cell vaso-occlusive crisis: it’s a gut feeling
por: Lim, Seah H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s8chk5t0gvlveiiroltuv123jp